These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34959613)

  • 1. First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Bal C
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the
    Läppchen T; Bilinska A; Pilatis E; Menéndez E; Imlimthan S; Moon ES; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of [
    Yadav MP; Ballal S; Martin M; Roesch F; Satapathy S; Moon ES; Tripathi M; Gogia A; Bal C
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):805-819. PubMed ID: 37932560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study.
    Ballal S; Yadav MP; Moon ES; Roesch F; Kumari S; Agarwal S; Tripathi M; Sahoo RK; Mangu BS; Tupalli A; Bal C
    Thyroid; 2022 Jan; 32(1):65-77. PubMed ID: 34641705
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[
    Kamaldeep ; Loharkar S; Das T; Basu S; Banerjee S
    Cancer Biother Radiopharm; 2022 Apr; 37(3):214-225. PubMed ID: 34910891
    [No Abstract]   [Full Text] [Related]  

  • 7. Examining Absorbed Doses of Indigenously Developed
    Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
    Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-Specific Membrane Antigen Radioligand Therapy Using
    Schuchardt C; Zhang J; Kulkarni HR; Chen X; Müller D; Baum RP
    J Nucl Med; 2022 Aug; 63(8):1199-1207. PubMed ID: 34887335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CXCR4/CXCL12 axis via [
    Bao G; Wang Z; Liu L; Zhang B; Song S; Wang D; Cheng S; Moon ES; Roesch F; Zhao J; Yu B; Zhu X
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2744-2757. PubMed ID: 38587644
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chopra S; Mathur Y; Roesch F; Moon ES; Rana N; Irrinki S; Walia R; Duseja A; Singh H; Kumar R; Shukla J; Mittal BR
    Acad Radiol; 2024 Jun; 31(6):2521-2535. PubMed ID: 38233261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Dosimetry for
    Okamoto S; Thieme A; Allmann J; D'Alessandria C; Maurer T; Retz M; Tauber R; Heck MM; Wester HJ; Tamaki N; Fendler WP; Herrmann K; Pfob CH; Scheidhauer K; Schwaiger M; Ziegler S; Eiber M
    J Nucl Med; 2017 Mar; 58(3):445-450. PubMed ID: 27660138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using
    Baum RP; Schuchardt C; Singh A; Chantadisai M; Robiller FC; Zhang J; Mueller D; Eismant A; Almaguel F; Zboralski D; Osterkamp F; Hoehne A; Reineke U; Smerling C; Kulkarni HR
    J Nucl Med; 2022 Mar; 63(3):415-423. PubMed ID: 34168013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inferior performance of [
    Has Simsek D; Guzel Y; Denizmen D; Sanli Y; Buyukkaya F; Kovan B; Komek H; Isik EG; Ozkan ZG; Kuyumcu S
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):828-840. PubMed ID: 37947850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics.
    Martin M; Ballal S; Yadav MP; Bal C; Van Rymenant Y; De Loose J; Verhulst E; De Meester I; Van Der Veken P; Roesch F
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Clinical Experience with
    Ferdinandus J; Costa PF; Kessler L; Weber M; Hirmas N; Kostbade K; Bauer S; Schuler M; Ahrens M; Schildhaus HU; Rischpler C; Grafe H; Siveke JT; Herrmann K; Fendler WP; Hamacher R
    J Nucl Med; 2022 May; 63(5):727-734. PubMed ID: 34385340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.
    Moon ES; Ballal S; Yadav MP; Bal C; Van Rymenant Y; Stephan S; Bracke A; Van der Veken P; De Meester I; Roesch F
    Am J Nucl Med Mol Imaging; 2021; 11(6):476-491. PubMed ID: 35003886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA
    Moon ES; Elvas F; Vliegen G; De Lombaerde S; Vangestel C; De Bruycker S; Bracke A; Eppard E; Greifenstein L; Klasen B; Kramer V; Staelens S; De Meester I; Van der Veken P; Rösch F
    EJNMMI Radiopharm Chem; 2020 Jul; 5(1):19. PubMed ID: 32728930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Ballal S; Yadav MP; Raju S; Roesch F; Martin M; Tripathi M; Bal C
    Nucl Med Mol Imaging; 2024 Feb; 58(1):32-34. PubMed ID: 38261876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.